Form 4: GE HealthCare Director Catherine Lesjak Awarded 3,092 Restricted Stock Units

GE HealthCare Technologies Inc. Director Catherine A. Lesjak was awarded 3,092 restricted stock units, increasing her beneficial ownership to 9,116 shares.

Summary

• Catherine A. Lesjak, a Director of GE HealthCare Technologies Inc. (GEHC), was awarded 3,092 restricted stock units (RSUs) on May 28, 2025.
• These RSUs were granted at a price of $0, indicating an award as part of compensation rather than a purchase.
• Following this transaction, Ms. Lesjak's total beneficial ownership in GE HealthCare common stock is 9,116 shares.
• The awarded RSUs will vest 100% on the earlier of GE HealthCare's next annual meeting of stockholders or May 28, 2026.
• Settlement of vested restricted stock units may be deferred by the reporting person in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan.

Sentiment

Score: 7

Explanation: The document reports a routine equity award to a director, which is a positive event as it aligns the director's interests with shareholders and indicates continued commitment to the company. It does not contain any negative or unexpected information.

Positives

• The award of restricted stock units aligns the director's financial interests more closely with those of the company's shareholders.
• The increase in the director's beneficial ownership demonstrates continued commitment to the company's long-term success.

Future Outlook

The vesting schedule for the awarded restricted stock units indicates future conversion into common stock, which is designed to align the director's incentives with the company's long-term performance and shareholder value creation.

Industry Context

The granting of equity awards, such as restricted stock units, to non-employee directors is a common and widely accepted practice in corporate governance across various industries. This mechanism is primarily used to align the interests of the board members with those of the shareholders, encouraging long-term commitment and performance.

Comparison to Industry Standards

• Granting restricted stock units (RSUs) to non-employee directors is a standard practice for large public companies like GE HealthCare, serving to align director incentives with long-term shareholder value.
• The vesting schedule, which is 100% on the earlier of the next annual meeting or a specific future date, is typical for director equity awards and is often tied to continued service.
• The provision allowing for deferral of settlement of vested RSUs is also a common feature in non-employee director compensation plans, offering flexibility for tax and financial planning.

Corporate Governance

Stakeholder Impact

• Shareholders: Positive, as the director's interests are further aligned with shareholder value through increased equity ownership.
• Employees: No direct impact mentioned in this filing.

Next Steps

• Vesting of the 3,092 restricted stock units on the earlier of GE HealthCare's next annual meeting of stockholders or May 28, 2026.
• Potential deferral of settlement of vested restricted stock units by the reporting person as per the company's compensation plan.

Key Dates

Recommendation

Keywords

GE HealthCare, GEHC, Form 4, SEC filing, insider transaction, restricted stock units, RSU, director compensation, equity award, beneficial ownership